Skip to main content
Mark Moster, MD, Neurology, Philadelphia, PA

Mark L Moster MD

Neuro-Ophthalmology


Professor of Neurology and Ophthalmology, Wills Eye Institute, Jefferson Medical College

Join to View Full Profile
  • 840 Walnut StSte 930Philadelphia, PA 19107

  • Phone+1 215-928-3130

Dr. Moster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Neuro-Ophthalmology, 1983 - 1984
  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Neurology, 1980 - 1983
  • UPMC Medical Education
    UPMC Medical EducationInternship, Internal Medicine, 1979 - 1980
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1979

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2005 - 2026
  • PA State Medical License
    PA State Medical License 1980 - 2026
  • NJ State Medical License
    NJ State Medical License 1989 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • GenSight Biologics Announces Publication of RESTORE Study Data Demonstrating Sustained Efficacy 3 Years After Unilateral Injection of LUMEVOQ®
    GenSight Biologics Announces Publication of RESTORE Study Data Demonstrating Sustained Efficacy 3 Years After Unilateral Injection of LUMEVOQ®August 31st, 2021
  • GenSight Biologics Reports Findings from REALITY Study and REVERSE-RESCUE Analysis Highlighting Positive Benefits from LUMEVOQ™ (GS010) Compared to LHON Natural History
    GenSight Biologics Reports Findings from REALITY Study and REVERSE-RESCUE Analysis Highlighting Positive Benefits from LUMEVOQ™ (GS010) Compared to LHON Natural HistoryDecember 11th, 2019
  • Literature Commentary
    Literature CommentarySeptember 30th, 2019
  • Join now to see all

Grant Support

  • Cerebral Cortical Mechanisms For Control Of SaccadesNational Institute Of Neurological Disorders And Stroke1990–1994

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: